NeuropathyLinked to Autoimmune Peripheral Central Tolerance to Myelin Protein Zero Is Defective Autoimmune Regulator-Dependent

Chronic inflammatory demyelinating polyneuropathy is a debilitating autoimmune disease characterized by peripheral nerve demyelination and dysfunction. How the autoimmune response is initiated, identity of provoking Ags, and pathogenic effector mechanisms are not well defined. The autoimmune regulator (Aire) plays a critical role in central tolerance by promoting thymic expression of self-Ags and deletion of self-reactive T cells. In this study, we used mice with hypomorphic Aire function and two patients with Aire mutations to define how Aire deficiency results in spontaneous autoimmune peripheral neuropathy. Autoimmunity against peripheral nerves in both mice and humans targets myelin protein zero, an Ag for which expression is Aire-regulated in the thymus. Consistent with a defect in thymic tolerance, CD4 + T cells are sufficient to transfer disease in mice and produce IFN- g in infiltrated peripheral nerves. Our findings suggest that defective Aire-mediated central tolerance to myelin protein zero initiates an autoimmune Th1 effector response toward peripheral nerves. The Journal of Immunology , 2012, 188: 000–000.

[1]  D. Geschwind,et al.  Specific Functions for ERK/MAPK Signaling during PNS Development , 2011, Neuron.

[2]  J. Ting,et al.  Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle , 2010, Journal of neuroscience research.

[3]  Mark S. Anderson,et al.  Identification of an Autoantigen Demonstrates a Link Between Interstitial Lung Disease and a Defect in Central Tolerance , 2009, Science Translational Medicine.

[4]  L. Melton,et al.  Incidence and prevalence of CIDP and the association of diabetes mellitus , 2009, Neurology.

[5]  Mark S. Anderson,et al.  A novel myelin P0–specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy , 2009, The Journal of experimental medicine.

[6]  M. Jensen,et al.  Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy1 , 2008, The Journal of Immunology.

[7]  Howard Y. Chang,et al.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. , 2008, The Journal of clinical investigation.

[8]  S. Miller,et al.  Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease , 2007, Nature Reviews Immunology.

[9]  Mark S. Anderson,et al.  Spontaneous autoimmunity prevented by thymic expression of a single self-antigen , 2006, The Journal of experimental medicine.

[10]  M. Pender,et al.  T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  Mark S. Anderson,et al.  The cellular mechanism of Aire control of T cell tolerance. , 2005, Immunity.

[12]  R. Hughes,et al.  Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy , 2005 .

[13]  B. Soliven,et al.  Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. , 2004, Frontiers in bioscience : a journal and virtual library.

[14]  Mark S. Anderson,et al.  Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.

[15]  H. Hartung,et al.  Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. , 2002, Brain : a journal of neurology.

[16]  A. Montag,et al.  Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice , 2001, The Journal of experimental medicine.

[17]  B. Winblad,et al.  P0 protein peptide 180‐199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice , 2000, Journal of neuroscience research.

[18]  R. Martini Animal models for inherited peripheral neuropathies , 2000, Journal of neuroscience research.

[19]  F. Chédru,et al.  Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy , 1999, Neurology.

[20]  J. McArthur,et al.  Quantitative analysis of endoneurial T-cells in human sural nerve biopsies , 1990, Journal of Neuroimmunology.